VGWCF - Valens GroWorks Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
3.2160
+0.0960 (+3.08%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close3.1200
Open3.1300
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range3.0700 - 3.2400
52 Week Range0.7936 - 3.6600
Volume154,597
Avg. Volume424,505
Market Cap390.146M
Beta (3Y Monthly)1.07
PE Ratio (TTM)N/A
EPS (TTM)-0.1050
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Valens Reports Record $8.8 Million in Revenue and Adjusted EBITDA of $2.0 Million in the Second Quarter of Fiscal 2019
    CNW Group5 days ago

    Valens Reports Record $8.8 Million in Revenue and Adjusted EBITDA of $2.0 Million in the Second Quarter of Fiscal 2019

    Gross profit increased to $5.1 million , or 58.0% of revenue, for the second quarter of 2019 compared to $0.9 million or 38.3% of revenue in the first quarter. Adjusted EBITDA(1) of $2.0 million in the second quarter, or 23.0% of revenue. Increased annual extraction capacity significantly to 425,000 KG of dried cannabis and hemp biomass in the second quarter of 2019 to meet increasing customer demand with plans to further increase capacity to over 1,000,000 KG per year with the buildout of the adjacent facility in Kelowna, BC anticipated to be completed in H1 2020.

  • Valens to Hold Conference Call to Discuss Financial Results for the Second Quarter of Fiscal 2019
    CNW Group11 days ago

    Valens to Hold Conference Call to Discuss Financial Results for the Second Quarter of Fiscal 2019

    Valens to Hold Conference Call to Discuss Financial Results for the Second Quarter of Fiscal 2019

  • Valens to Commence Trading on the TSX Venture Exchange
    PR Newswire12 days ago

    Valens to Commence Trading on the TSX Venture Exchange

    KELOWNA, BC , July 8, 2019 /PRNewswire/ -  Valens GroWorks Corp. (CSE: VGW) (OTC: VGWCF)  (the " Company " or " Valens "), a multi-licensed, vertically integrated provider of cannabis ...

  • Why Medicare for all could 'dramatically' increase access to medical marijuana
    Yahoo Finance19 days ago

    Why Medicare for all could 'dramatically' increase access to medical marijuana

    Medicare for all may not be just a Democratic talking point as the 2020 campaign kicks into high gear. It could also “dramatically” increase access to medical marijuana, according to Nicholas Vita, CEO of cannabis company Columbia Care.

  • Benzinga26 days ago

    The Secret Sauce Behind The Best Performing Cannabis ETF In Canada

    Some of those may have gained their wealth through the Evolve Marijuana ETF (TSE:SEED) (OTC: EVVLF), which, in the last year, has delivered the best performance among all cannabis ETFs. Need more cannabis news? Evolve launched SEED on the Toronto Stock Exchange roughly 14 months ago.

  • Valens substantially increases annual extraction capacity to 425,000KG with plans to increase capacity to over 1,000,000KG
    CNW Grouplast month

    Valens substantially increases annual extraction capacity to 425,000KG with plans to increase capacity to over 1,000,000KG

    KELOWNA, BC , June 18, 2019 /CNW/ - Valens GroWorks Corp. (VGW.CN) (VGWCF) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing, is pleased to announce it has substantially increased its annual extraction capacity to 425,000KG of dried cannabis and hemp biomass. As the largest third-party extraction company in Canada , Valens continues to experience significant demand for its services and are accelerating its growth to ensure the Company continues to meet the growing demand of its partners for both extraction and white label product development.

  • Valens Receives Conditional Listing Approval on TSXV and Accelerates Q2 Filing Date
    PR Newswirelast month

    Valens Receives Conditional Listing Approval on TSXV and Accelerates Q2 Filing Date

    KELOWNA, BC, June 17, 2019 /PRNewswire/ - Valens GroWorks Corp. (VGW.CN) (VGWCF) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing is pleased to announce that it has received conditional approval to list the common shares and warrants of the Company on the TSX Venture Exchange as a Tier 1 life sciences issuer. The listing is subject to the company fulfilling certain requirements of the TSXV in accordance with the terms of its conditional approval letter dated June 14, 2019.

  • The Single Most Important Thing HEXO Said in Its Third-Quarter Report
    Motley Foollast month

    The Single Most Important Thing HEXO Said in Its Third-Quarter Report

    Hint: It had nothing to do with the company's headline numbers.

  • Valens Expands Size and Scope of Agreement With Tilray
    PR Newswirelast month

    Valens Expands Size and Scope of Agreement With Tilray

    KELOWNA, BC, June 10, 2019 /PRNewswire/ - Valens GroWorks Corp. (CSE: VGW, OTC: VGWCF) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing is pleased to announce that it has expanded the volume of extraction services and has added an option to provide contract manufacturing services to the arm's length, binding multi-year agreement (the "Agreement") previously announced February 26, 2019 with Tilray Inc. ("Tilray") (TLRY), a global leader in cannabis research, cultivation, production and distribution. Under the initial two-year term of the expanded Agreement, Valens will extract on a fee for service basis a minimum annual quantity of 60,000kg of dried cannabis and hemp biomass, up 300% from the 15,000kg annual commitment outlined in the original agreement.

  • CNW Grouplast month

    Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing

    Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing

  • CNW Group2 months ago

    Live Investor Conference & Webinar: Cannabis Industry Companies Present June 4th

    Live Investor Conference & Webinar: Cannabis Industry Companies Present June 4th

  • Valens signs multi-year cannabis extraction agreement with Tantalus Labs
    CNW Group2 months ago

    Valens signs multi-year cannabis extraction agreement with Tantalus Labs

    KELOWNA, BC , May 28, 2019 /CNW/ - Valens GroWorks Corp. (VGW.CN) (VGWCF) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing is pleased to announce that it has entered into an arm's length binding multi-year extraction services agreement (the "Agreement") to provide cannabis extraction services to Tantalus Labs ("Tantalus"), a leading British-Columbia -based cannabis producer. The Agreement has an initial 2-year term from the date of the first shipment from Tantalus. Valens will process the cannabis biomass provided by Tantalus on a fee for service basis into premium quality resins and distillates using the Company's leading proprietary extraction processing methods.

  • Valens Appoints President Focused on Growth Opportunities
    CNW Group2 months ago

    Valens Appoints President Focused on Growth Opportunities

    KELOWNA, BC , May 27, 2019 /CNW/ - Valens GroWorks Corp. (VGW.CN) (VGWCF) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies including distillation, cannabinoid isolation and purification, product formulation and development as well as associated quality testing announced today that Jeffrey Fallows , LLB/MBA, CFA has been appointed as President of Valens, effective June 1, 2019 .  Mr. Fallows will be focused on executing on domestic and international growth opportunities, capital markets strategy and assisting with the overall corporate strategy of the Company.

  • Leading International Cannabis Expert Joins Valens Board of Directors
    CNW Group2 months ago

    Leading International Cannabis Expert Joins Valens Board of Directors

    KELOWNA, B.C. , May 13, 2019 /CNW/ - Valens GroWorks Corp. (VGW.CN) (VGWCF) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing announced today that Deepak Anand has been appointed to its Board of Directors as an independent member. Mr. Anand is recognized as a thought leader in the global cannabis space.